Carroll Financial Associates’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $179K | Sell |
782
-99
| -11% | -$21.8K | 0.01% | 405 |
|
|
2021
Q3 | $170K | Buy |
881
+2
| +0.2% | +$405 | 0.01% | 426 |
|
|
2021
Q2 | $186K | Sell |
879
-376
| -30% | -$79.4K | 0.01% | 427 |
|
|
2021
Q1 | $256K | Buy |
1,255
+579
| +86% | +$114K | 0.02% | 354 |
|
|
2020
Q4 | $123K | Sell |
676
-50
| -7% | -$8.5K | 0.01% | 473 |
|
|
2020
Q3 | $121K | Sell |
726
-348
| -32% | -$58.6K | 0.01% | 438 |
|
|
2020
Q2 | $174K | Buy |
1,074
+25
| +2% | +$4.48K | 0.01% | 357 |
|
|
2020
Q1 | $181K | Buy |
1,049
+7
| +0.7% | +$1.39K | 0.02% | 316 |
|
|
2019
Q4 | $209K | Buy |
1,042
+100
| +11% | +$20.5K | 0.02% | 353 |
|
|
2019
Q3 | $199K | Sell |
942
-51
| -5% | -$10.7K | 0.02% | 365 |
|
|
2019
Q2 | $192K | Buy |
993
+331
| +50% | +$61K | 0.02% | 359 |
|
|
2019
Q1 | $108K | Buy |
662
+157
| +31% | +$27.8K | 0.01% | 432 |
|
|
2018
Q4 | $92K | Hold |
505
| – | – | 0.01% | 386 |
|
|
2018
Q3 | $85K | Buy |
505
+11
| +2% | +$1.85K | 0.01% | 425 |
|
|
2018
Q2 | $80K | Buy |
494
+180
| +57% | +$29.4K | 0.01% | 427 |
|
|
2018
Q1 | $50K | Hold |
314
| – | – | 0.01% | 485 |
|
|
2017
Q4 | $45K | Hold |
314
| – | – | ﹤0.01% | 506 |
|
|
2017
Q3 | $43K | Hold |
314
| – | – | ﹤0.01% | 513 |
|
|
2017
Q2 | $39K | Sell |
314
-37
| -11% | -$4.42K | ﹤0.01% | 542 |
|
|
2017
Q1 | $41K | Hold |
351
| – | – | 0.01% | 511 |
|
|
2016
Q4 | $40K | Sell |
351
-49
| -12% | -$5.45K | 0.01% | 495 |
|
|
2016
Q3 | $41K | Buy |
400
+313
| +360% | +$32.7K | 0.01% | 493 |
|
|
2016
Q2 | $8K | Hold |
87
| – | – | ﹤0.01% | 831 |
|
|
2016
Q1 | $8K | Sell |
87
-97
| -53% | -$8.82K | ﹤0.01% | 808 |
|
|
2015
Q4 | $16K | Buy |
184
+35
| +23% | +$3.29K | ﹤0.01% | 632 |
|
|
2015
Q3 | $13K | Buy |
149
+7
| +5% | +$665 | ﹤0.01% | 661 |
|
|
2015
Q2 | $13K | Buy |
142
+45
| +46% | +$4.2K | ﹤0.01% | 652 |
|
|
2015
Q1 | $9K | Hold |
97
| – | – | ﹤0.01% | 528 |
|
|
2014
Q4 | $9K | Sell |
97
-25
| -20% | -$2.12K | 0.01% | 495 |
|
|
2014
Q3 | $10K | Hold |
122
| – | – | ﹤0.01% | 555 |
|
|
2014
Q2 | $9K | Hold |
122
| – | – | ﹤0.01% | 611 |
|
|
2014
Q1 | $9K | Buy |
122
+25
| +26% | +$1.89K | ﹤0.01% | 544 |
|
|
2013
Q4 | $7K | Hold |
97
| – | – | ﹤0.01% | 561 |
|
|
2013
Q3 | $7K | Hold |
97
| – | – | ﹤0.01% | 576 |
|
|
2013
Q2 | $7K | Buy |
+97
| New | +$6.36K | ﹤0.01% | 458 |
|
Other funds holding CME
Carroll Financial Associates's CME Position: Q4 2021 in Review
Carroll Financial Associates reduced its CME Group (CME) stake by 11% in Q4 2021, selling an estimated $21.8K and leaving 782 shares worth $179K. The position accounts for 0.01% of the portfolio, ranked #405.
Carroll Financial Associates first reported a position in CME in Q2 2013 and has held it in 35 quarters since. The position peaked at $256K in Q1 2021. 1,147 funds tracked by Wall St. Rank hold CME as of Q4 2021.
- Carroll Financial Associates held 782 shares of CME Group worth $179K as of Q4 2021.
- Carroll Financial Associates sold 99 CME Group shares in Q4 2021, an estimated $21.8K.
- CME Group made up 0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #405 holding.
- Carroll Financial Associates first reported a position in CME Group in Q2 2013 and has held it in 35 quarters since.
- Carroll Financial Associates's CME Group position peaked at $256K in Q1 2021.
- 1,147 funds tracked by Wall St. Rank held CME Group as of Q4 2021.
Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.